Erythema nodosum and granulomatous lesions preceding acute myelomonocytic leukemia

Journal of Dermatology

Volumn 31, Issue 9, 2004, Pages 741-747

  Anan, Takashi ^a   Imamura, Tomoyuki ^a   Yokoyama, Shigeo ^a   Fujiwara, Sakuhei ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Acute myelomonocytic leukemia, tumor necrosis factor alpha; Erythema nodosum; Granuloma; Interleukin 1 beta

Indexed keywords

ACLARUBICIN; DAUNORUBICIN; ENOCITABINE; ETOPOSIDE; INTERLEUKIN 1BETA; MITOXANTRONE; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE MYELOMONOCYTIC LEUKEMIA; AGED; ARTICLE; BLAST CELL; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; ERYTHEMA NODOSUM; FEMALE; GRANULOMATOUS SKIN DISEASE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKEMIA REMISSION; LEUKOCYTOSIS; PAIN; RASH; RECURRENT DISEASE; SKIN BIOPSY; SYMPTOM;

EID: 6944247407     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2004.tb00588.x     Document Type: Article

References (27)

1. Ratnam KV, Khor CJ, Su WP: Leukemia cutis, Dermatol Clin, 12: 419-431, 1994.
2. Sumaya CV, Babu S, Reed RJ: Erythema nodosum-like lesions of leukemia, Arch Dermatol, 110: 415-418, 1974.
3. Naschitz JE, Rosner I, Rozenbaum M, Zuckerman E, Yeshurun D: Rheumatic Syndromes: Clues to occult neoplasia, Semin Arthritis Rheum, 29: 43-55, 1999.
4. Shaikh BS, Frantz E, Lookingbill DP: Histologically proven leukemia cutis carries a poor prognosis in acute nonlymphocytic leukemia, Cutis, 39: 57-60, 1987.
5. Bonci A, Lernia VD, Merli F, Scocco GL: Erythema nodosum and Hodgkins' lymphoma, Clin Exp Dermatology, 26: 408-411, 2001.
6. Setoyama M, Katahira Y, Kanzaki T, Kerdel FA, Byrnes JJ: Adult T-cell leukemia/lymphoma associated with noninfectious epithelioid granuloma in the skin: A clinicopathologic study, Am J Dermatopathol, 19: 591-595, 1997.
7. Fischer M, Wohlrab J, Audring TH, Sterry W, Marsch WC: Granulomatous mycosis fungoides. Report of two cases and review of the literature, J Eur Acad Dermatol Venereol, 14: 196-202, 2003.
8. Horiuchi Y, Masuzawa M, Nozaki O, Shibahara N, Shiga T, Yoshida M: Unusual cutaneous lesions associated with chronic myelomonocytic leukemia, Clin Exp Dermatol, 17: 121-124, 1992.
9. Baksh FK, Nathan D, Richardson W, Kestenbaum T, Woodroof J: Leukemia cutis with prominent giant cell reaction, Am J Dermatopathol, 20: 48-52, 1998.
10. Kaddu S, Zenahlik P, Beham-Schmid C, Kerl H, Cerroni L: Specific cutaneous infiltrates in patients with myelogenous leukemia: A clinicopathologic study of 26 patients with assessment of diagnostic criteria, J Am Acad Dermatol, 40: 966-978, 1999.
11. Kaiserling E, Horny HP, Geerts ML, Schmid U: Skin involvement in myelogenous leukemia: Morphologic and immunophenotypic heterogeneity of skin infiltrates, Mod Pathol, 7: 771-779, 1994.
12. Baden TJ, Gammon WR: Leukemia cutis in acute myelomonocytic leukemia, Arch Dermatol, 123: 88-90, 1987.
13. Tomasini C, Quaglino P, Novelli M, Fierro MT: "Aleukemic" granulomatous leukemia cutis, Am J Dermatopathol, 20: 417-421, 1998.
14. Chensue SW, Otterness IG, Higashi GI, Forsch CS, Kunkel SL: Monokine production by hypersensitivity (Schistosoma mansoni egg) and foreign body (Sephadex bead)-type granuloma macrophages. Evidence for sequential production of IL-1 and tumor necrosis factor, J Immunol, 142: 1281-1286, 1989.
15. Labunski S, Posern G, Ludwig S, Kundt G, Bröcker EB, Kunz M: Tumor necrosis factor-α promoter polymorphism in erythema nodosum, Acta Derm Venereol, 81: 18-21, 2001.
16. Düzgün N, Ayaslioglu E, Tutkak H, Aydintug OT: Cytokine inhibitors: Soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet's disease, Rheum Int (in press).
17. Abe M, Ohnishi K, Hasegawa M, et al: The antipsoriatic effect of thiamazole is not accompanied either by significant changes in blood lymphocyte subsets nor by serum concentration of TNF-alpha, Eur J Dermatol, 12: 335-339, 2001.
18. Iorio AD, Ferrucci L, Sparvieri E, et al: Serum IL-beta levels in health and disease: A population-based study. 'The InCHIANTI study', Cytokine, 22: 198-205, 2003.
19. Cochran FR, Finch-Arietta MB: Regulation of interleukin-1 beta and tumor necrosis factor secretion by the human monocytic leukemia cell line, THP-1, Agents Actions, 27: 271-273, 1989.
20. Fisher G, Jaworski R: Granuloma formation in herpes zoster scars, J Am Acad Dermatol, 16: 1261-1263, 1987.
21. Wright AL, Cotton DWK, Winfield DA, Messenger AG: Granuloma formation in herpes zoster scars, Dermatologica, 179: 45-46, 1989.
22. Pujol RM, Matias-Guiu X, Planaguma M, de Moragas JM: Chronic lymphocytic leukemia and cutaneous granulomas at sites of herpes zoster scars, Int J Dermatol, 29: 652-654, 1990.
23. Vestey JP, Turner M, Biddlestone L, McLaren K, Goulden N, Hunter JA: Disseminated cutaneous granulomatous eruptions associated with myelodysplastic syndrome and acute myeloid leukaemia, Clin Exp Dermatol, 18: 559-563, 1993.
24. Huilgol SC, Liddell K, Black MM: Generalized grannuloma annulare sparing vaccination site, Clin Exp Dermatol, 20: 51-53, 1995.
25. Isoda M: Cutaneous sarcoid reactions during long term remission in patient with acute myelogenous leukemia, J Dermatol, 23: 293-295, 1996.
26. Jee MS, Kim ES, Chang SE, Lee MW, Koh JK: Disseminated granuloma annulare associated with chronic myelogenous leukemia, J Dermatol, 30: 631-633, 2003.
27. Katz KA: Disseminated cutaneous granulomatous eruption occurring in the setting of myelodysplasia, Dermatol Online J, 9: 22, 2003.